Miebo for Evaporative Dry Eye in Nampa

Prescription treatment targeting tear evaporation

What is Miebo?

Miebo (perfluorohexyloctane ophthalmic solution) is an FDA-approved prescription eye drop for the signs and symptoms of dry eye disease. It is a water free, preservative free formulation used to address excessive tear evaporation. At EnVision Dry Eye Center, it may be considered when examination findings suggest that an unstable tear film is contributing to your symptoms.

Why does tear evaporation matter?

The tears must remain on the eye long enough to protect its surface between blinks. Meibomian glands in the eyelids supply oils that help limit evaporation. When these glands do not function well, tears can become unstable even when the eye can produce watery tears. Symptoms may include burning, grittiness, and fluctuating vision.

Related Question: What Is Meibomian Gland Dysfunction?

How does Miebo work?

Perfluorohexyloctane spreads at the air–tear interface and forms a thin layer that is expected to reduce evaporation. The prescribing information notes that its exact mechanism in dry eye disease is not fully known. Its role differs from directly stimulating tear production or using a corticosteroid to treat inflammation.

Reducing evaporation does not mean damaged meibomian glands have regrown or every underlying problem has been corrected. Eyelid care or other treatment may still be appropriate.

How do we determine whether it is appropriate?

Dr. Jason Besecker considers your symptoms, tear stability, meibomian gland findings, and ocular surface health together. Meibography and tear breakup time testing can help explain why tears are not staying stable. We also review your current drops and contact lens routine before recommending a plan.

Explore: Non-Invasive Tear Breakup Time

What have clinical studies shown?

The GOBI and MOJAVE trials enrolled patients with dry eye disease and clinical signs of meibomian gland dysfunction. Compared with saline control drops, perfluorohexyloctane produced greater improvements in eye dryness scores and corneal surface staining over the eight week treatment period. The pooled analysis supports benefits in both symptoms and an objective sign of surface damage.

Study averages do not predict an individual result. Follow up allows us to assess whether changes in comfort, vision, and surface findings justify continuing or adjusting treatment.

How is Miebo used?

The labeled regimen is one drop in the affected eye or eyes four times daily. Follow the bottle’s specific instructions for drawing air into the bottle before dispensing a drop. Our team can review the technique with you.

Remove contact lenses before use and wait at least 30 minutes before reinserting them.
Keep the bottle tip from touching the eye or other surfaces.
Use the medication as prescribed and ask how to coordinate it with other drops.

What side effects and precautions should I know?

Blurred vision and eye redness were reported in 1–3% of patients in pivotal studies. Do not use Miebo if you have had an allergic reaction to perfluorohexyloctane. Tell your prescriber if you are pregnant or breastfeeding. Safety and effectiveness below age 18 have not been established.

Contact the clinic for persistent irritation, pain, worsening redness, or vision changes. Review the complete prescribing information below for additional precautions.

How does it fit with other dry eye care?

Your plan may combine medication with care directed at the eyelids and glands. Bring your home care routine and all eye drops to your evaluation so we can build a practical schedule. We will identify the purpose of each treatment and discuss how its effect will be assessed.

Explore: Dry Eye Center

Request a comprehensive dry eye evaluation

Ready to take the next step? Let’s find out what is behind your symptoms. Request an evaluation with EnVision Dry Eye Center in Nampa, serving Boise, Meridian, Caldwell, and the Treasure Valley.

EnVision Dry Eye Center
3752 E Amity Avenue, Suite 103
Nampa, Idaho 83687
(208) 490-8823

Request a Comprehensive Dry Eye Evaluation

Medically reviewed by Jason Besecker, OD, MS
Last updated: October 2026

Explore: Dry Eye Questions & Answers